Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (111-120 of 899) with videos related to

Pageof 90
Sort By:
Experimental Hematology|March 1, 1993
Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporineT P Loughran, H J Deeg, R Storb
Tissue Antigens|June 21, 2002
Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine Major Histocompatibility ComplexJ L Wagner, U M Sarmiento, R Storb
The New England Journal of Medicine|March 25, 1982
Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosisB M Camitta, R Storb, E D Thomas
The New England Journal of Medicine|March 18, 1982
Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosisB M Camitta, R Storb, E D Thomas
JAMA|September 15, 1978
Marrow transplantation for leukemiaE D Thomas, C D Buckner, R Storb
Blood|October 15, 1992
Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II moleculesH T Greinix, R Storb, S H Bartelmez
Journal of the Reticuloendothelial Society|June 1, 1975
Marrow origin of canine alveolar macrophagesP L Weiden, R Storb, M S Tsoi
The Journal of Clinical Investigation|April 1, 1977
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survivalR Storb, R L Prentice, E D Thomas
Transplantation|January 1, 1994
A simple restriction fragment-length polymorphism assay for MHC class II gene testing of dog familiesR C Burnett, S A DeRose, R Storb
Journal of Leukocyte Biology|February 1, 1991
Inhibition of cluster formation and lymphocyte proliferation by anti-fibronectin antiserumH G Klingemann, R Storb, H J Deeg
Pageof 90

Showing results (111-120 of 899) with videos related to

Sort By:
Pageof 90
Experimental Hematology|March 1, 1993
Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporineT P Loughran, H J Deeg, R Storb
Tissue Antigens|June 21, 2002
Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine Major Histocompatibility ComplexJ L Wagner, U M Sarmiento, R Storb
The New England Journal of Medicine|March 25, 1982
Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosisB M Camitta, R Storb, E D Thomas
The New England Journal of Medicine|March 18, 1982
Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosisB M Camitta, R Storb, E D Thomas
JAMA|September 15, 1978
Marrow transplantation for leukemiaE D Thomas, C D Buckner, R Storb
Blood|October 15, 1992
Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II moleculesH T Greinix, R Storb, S H Bartelmez
Journal of the Reticuloendothelial Society|June 1, 1975
Marrow origin of canine alveolar macrophagesP L Weiden, R Storb, M S Tsoi
The Journal of Clinical Investigation|April 1, 1977
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survivalR Storb, R L Prentice, E D Thomas
Transplantation|January 1, 1994
A simple restriction fragment-length polymorphism assay for MHC class II gene testing of dog familiesR C Burnett, S A DeRose, R Storb
Journal of Leukocyte Biology|February 1, 1991
Inhibition of cluster formation and lymphocyte proliferation by anti-fibronectin antiserumH G Klingemann, R Storb, H J Deeg
Pageof 90